NDC 61314-651 – Pyzchiva

Ustekinumab 45 mg/.5mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC61314-651

Product details

Brand name
Pyzchiva
Generic name
Ustekinumab-ttwe
Labeler
SANDOZ INC
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA761373
Marketed since
February 22, 2025
Listing expires
December 31, 2027
Pharmacologic class
Interleukin-12 Antagonist; Interleukin-23 Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Pyzchiva →

Package NDC codes (2)

Package NDCDescriptionSince
61314-651-011 SYRINGE in 1 CARTON (61314-651-01) / .5 mL in 1 SYRINGEFeb 22, 2025
61314-651-941 VIAL in 1 CARTON (61314-651-94) / .5 mL in 1 VIALJun 23, 2025

Other Pyzchiva products